top of page
A NEW GENERATION OF IMMUNOTHERAPIES
The Latest Press Releases
January 23rd, 2024
AyuVis Research Receives FDA Clearance for AVR-48 to Proceed with a Phase 1 Clinical Study
November 30th, 2023
AyuVis Research Selected for Virtual BLUE KNIGHT™ and Johnson & Johnson Innovation – JLABS Residency
April 19th, 2023
EY Announces SUCHISMITA ACHARYA of AYUVIS
as an Entrepreneur of The Year® 2023 Southwest Award Finalist
AUGUST 1, 2022
AyuVis Selected for MassChallenge Accelerator 2022 Cohort
MAY 13, 2022
AyuVis Awarded $1.8M Grant to Support Pediatric Drug Development Program
MARCH 31, 2022
AyuVis Receives Second Patent Approval from USPTO, Australia
February 13, 2022
Startup AyuVis’ First Patent Granted in U.S., 3 Other Countries
bottom of page